Stress Induced Glial Changes in Neurological DisordersView this Special Issue
Research Article | Open Access
Miao Yang, Wuqing Sun, Lu Xiao, Mulan He, Yan Gu, Ting Yang, Jie Chen, Xiaohua Liang, "Mesenchymal Stromal Cells Suppress Hippocampal Neuron Autophagy Stress Induced by Hypoxic-Ischemic Brain Damage: The Possible Role of Endogenous IL-6 Secretion", Neural Plasticity, vol. 2020, Article ID 8822579, 12 pages, 2020. https://doi.org/10.1155/2020/8822579
Mesenchymal Stromal Cells Suppress Hippocampal Neuron Autophagy Stress Induced by Hypoxic-Ischemic Brain Damage: The Possible Role of Endogenous IL-6 Secretion
Background. Increasing evidence has revealed that mesenchymal stromal cell (MSC) transplantation alleviates hypoxic-ischemic brain damage (HIBD) induced neurological impairments via immunomodulating astrocyte antiapoptosis effects. However, it remains unclear whether MSCs regulate neuron autophagy following HIBD. Results. In the present study, MSC transplantation effectively ameliorated learning-memory function and suppressed stress-induced hippocampal neuron autophagy in HIBD rats. Moreover, the suppressive effects of MSCs on autophagy were significantly weakened following endogenous IL-6 silencing in MSCs. Suppressing IL-6 expression also significantly increased p-AMPK protein expression and decreased p-mTOR protein expression in injured hippocampal neurons. Conclusion. Endogenous IL-6 in MSCs may reduce autophagy in hippocampal neurons partly through the AMPK/mTOR pathway.
Hypoxic-ischemic brain damage (HIBD) in neonates may cause permanent brain damage, resulting in nervous system disability or even infantile mortality . The hippocampus is easily damaged during the early stages of ischemia . Necrosis, apoptosis, and autophagy are the main pathways of neuron death . Recently, increased autophagy levels have been demonstrated following cerebral ischemia [4, 5]. It was reported that activation of autophagy after ischemia/reperfusion could be induced in neurons and astrocytes .
In the neuronal system, moderate autophagy is thought to be neuroprotective because it clears aggregated proteins associated with neurodegeneration, but both defective autophagy and excess autophagy may result in neuronal death [7–9]. More and more studies have demonstrated the involvement of autophagy in cerebral ischemic stroke; however, it remains unclear what effects transplanted mesenchymal stromal cells (MSCs) have on autophagy following ischemic cerebral injury.
Stem cells have potential biofunctions that induce tissue repair and regeneration. Numerous studies have demonstrated that MSC transplantation is neuroprotective in HIBD [10, 11]. MSCs could induce autolysosome formation and autophagy-dependent Aβ clearance in an Alzheimer’s disease animal model to exert neuroprotective effects . What is more, the results of our previous study indicated that IL-6 in the coculture medium was from MSCs, not injured neurons to play a neuroprotective role in HIBD rats .
Therefore, we speculated that the neuroprotective function of MSCs might partially regulate hippocampal autophagy in HIBD rats via IL-6 secretion. A series of experiments were designed to verify the above hypothesis. First, we evaluated the effects of MSCs on hippocampal neuron autophagy both in vivo and in vitro. Second, IL-6-silenced MSCs were used to verify the role of IL-6 in regulating autophagy. Finally, we tried to reveal the potential mechanisms of MSC-derived IL-6 to regulate hippocampal autophagy. This study may provide an experimental basis for the clinical application of MSCs.
2. Experimental Procedures
2.1. Animal Groups
Specific pathogen-free (SPF) grade Sprague Dawley (SD) rats (8 weeks old) were obtained from the Animal Center of Chongqing Medical University (Chongqing, China), and all animal experimental procedures followed the rules of the Animal Ethics Committee of Chongqing Medical University. The rats were fed in an SPF room at 25°C and 55-65% humidity with a 12 h light/dark cycle. At postnatal day 7, the pups were divided into a sham group () and a HIBD group () by the random number method. The HIBD group was subjected to HIBD injury as reported previously . Briefly, the left carotid artery was ligated continuously, after two hours, the pups were then exposed to 8% oxygen at 37°C for 2.5 h. The pups in the sham group were subjected to only a cervical skin incision and subsequently sutured. The HIBD pups received intracerebroventricular transplants of MSCs, siIL-6 MSCs, or GFP MSCs in 5 μl phosphate-buffered saline (PBS) (HyClone, USA) following HIBD for 30 min . The intracerebroventricular injection was carried out 1.2 mm posterior to the bregma and 1.2 mm to the left of the lambdoid suture with a needle depth of 3.5 mm at a rate of 1 μl/min for 5 min. The needle was kept in place for 2 min and then withdrawn slowly. The HIBD pups were injected with the same volume of PBS as the transplant negative control group. All of the operative SD rats were anesthetized at a dose of 40 mg/kg (intraperitoneal injection), and the concentration of pentobarbital sodium was 2%. To collect fresh hippocampal tissue, the rats were deeply anesthetized with 20% urethane at a dose of 1 g/kg (intraperitoneal injection), while the rats were performed to euthanasia by inhalation of CO2 at a 20% volume displacement per minute after the Morris water maze experiment.
2.2. Morris Water Maze
Four weeks after HIBD, the rats of the sham group (), the HIBD group (), and the HIBD+MSC group () were evaluated for their spatial learning-memory functions with the Morris water maze task (MWM SLY-WMS 2.0, China) as previously described . Briefly, the entire procedure was performed for six days. The first day, the rats’ visual capabilities were assessed by visible platform tests, and from the 2nd to 5th days, the learning-memory function of the rats was trained with an invisible platform. On the 6th day, a probe trial was performed without the platform, and the number of times that the rats crossed the former platform location in 60 s was recorded.
2.3. Preparation of MSCs and Treatment
Primary MSCs were isolated from rats and amplified with plastic adherence methods. The rat siIL-6-transduced recombinant lentivirus was constructed by NeuronBiotech Co., Ltd. The 4 different shRNA sequences were designed (GR425, GR426, GR427, and GR428) in a vector expressing green fluorescent protein (GFP), and the control sequence (TTCTCCGAACGTGTCACGT) served as a negative control (GFP MSCs) . The siIL-6- and GFP-transduced recombinant lentiviruses were infected into the MSCs with virus titer of and IL-6 concentration was decreased by 70-80% .
2.4. Primary Hippocampal Neuron Injury
Primary cultures of hippocampal neurons were prepared from SD rats at embryonic days 17-18. The hippocampal neurons were cultured for 5 days in an incubator with 5% CO2 (Thermo, USA). For oxygen-glucose deprivation (OGD) injury, the hippocampal neurons were subjected to EBSS medium and exposed to 5% O2/5% CO2 for 1.5 h as described previously ; then, the EBSS was changed to standard neuronal culture medium. Cells cultured with standard neuronal culture medium in the presence of ambient (16%) O2/5% CO2 served as a control. The injured neurons were placed in Transwell inserts (Millipore, USA) for separate coculture with either (1) neural basal medium as a control or (2) MSCs subjected to the different treatments described above. After 12 h and 24 h, total protein was extracted using an extraction kit (BioTeke, China).
We found that the levels of Beclin 1 and LC3 II protein expressions were significantly increased in the rat hippocampus at 12-24 h following HIBD . Meanwhile, OGD treatment upregulated autophagy-associated protein expression in primary neurons in vitro at 12 h.
2.5. Western Blotting
Total protein was extracted from the primary neurons and hippocampus for western blotting. The membranes were incubated in primary antibodies against Beclin 1 (1 : 1000, Abcam, USA), anti-LC3 II, anti-p62 (1 : 1000, Sigma, USA), anti-p-mTOR, anti-p-AMPK (1 : 1000, CST, USA), anti-IL-6 (1 : 500, R&D, China), and anti-β-actin (1 : 500, Santa Cruz, USA) at 4°C overnight. After incubation with HRP-conjugated secondary antibodies (Santa Cruz, USA) at room temperature for 1 h, the protein bands were developed using a chemiluminescent HRP substrate (Millipore, USA). Images were captured with a Syngene GBox Imaging System (Syngene, Europe Oxford, UK). The expression level of each protein was analyzed according to β-actin normalization.
2.6. Transmission Electron Microscopy
Primary neurons were digested with 0.1% trypsin and collected by centrifugation at 1200 rpm for 10 min. The neuron pellets were fixed in 4% glutaraldehyde and then postfixed in 1% osmium tetroxide. Following dehydration in a graded ethanol series, the samples were cut into ultrathin slices (40-60 nm thick), double stained with uranyl acetate and lead citrate, and observed by TEM (H-7500).
2.7. Statistical Analyses
Statistical analyses were performed using Statistical Product and Service Solutions 20 software. The values are presented as the (SEM). Each experiment was repeated at least three times and analyzed by Student’s -test or one-way ANOVA with the least significant difference post hoc test. The escape latencies of the rats in the three groups were determined using ANOVA for repeated measurement. The least significant difference test was used to compare the mean of two or more groups. was considered statistically significant.
3.1. MSC Transplantation Downregulates Hippocampal Autophagy
Beclin 1 is a positive regulator of autophagy, LC3 II can reflect autophagical activity, and p62 is one of the selective substrates for autophagy. To evaluate the effect of MSCs on autophagy in the hippocampal neurons of neonatal rats with HIBD, we measured the autophagy-related proteins Beclin 1, LC3 II, and p62 in the hippocampus 12 h and 24 h after MSC transplantation. As shown in Figures 1(a) and 1(b), MSC transplantation significantly decreased Beclin 1 expression levels in the hippocampus of HIBD rats, whereas these levels were markedly increased in HIBD rats. The changes in LC3 II expression levels were highly consistent with those of Beclin 1 (Figures 1(a) and 1(c)). However, the levels of p62 protein expression were significantly increased in the HIBD hippocampus at 12 h and 24 h after MSC transplantation (Figures 1(a) and 1(d)). The above results demonstrated that MSC transplantation may regulate the level of hippocampal autophagy.
3.2. MSC Transplantation Alleviates Cognitive Impairment in HIBD Rats
Impairment in learning-memory function is one of the major changes after HIBD. To confirm the effects of MSC transplantation on memory damage in HIBD rats, we conducted MWM tests. As shown in Figures 2(a) and 2(b), the escape latency and path length to locate the platform were not significantly different among the sham, HIBD, and HIBD+MSC groups on the first day, which indicates that neither HIBD nor MSC transplantation affected the motility or vision of the rats. During the training period with the hidden platform from the 2nd to 5th day, the escape latencies decreased progressively for all groups. However, the rats in the HIBD+MSC group spent less time locating the platform than those in the HIBD group but more time than those in the sham group (Figure 2(c)). Pairwise comparisons between different treatment groups showed statistically significant differences ( vs. the sham group; ## vs. the HIBD+MSC group). The difference between days was significant (). There was no interaction between group and day (). In the spatial probe test on the 6th day, the number of times passed through the original platform region was higher for HIBD+MSC rats than for HIBD rats, which passed through the original platform region the least number of times among the three groups (Figure 2(d)). These results suggest that MSC transplantation may regulate the level of hippocampal autophagy to alleviate memory impairment in HIBD rats.
3.3. MSC Coculture Reduces Autophagy and Decreases the Autophagosome Number in Primary Hippocampal Neurons following OGD
To clarify the role of MSCs in regulating autophagy, we separately cocultured OGD-injured primary hippocampal neurons with MSCs. As shown in Figures 3(a)–3(d), OGD treatment obviously increased the Beclin 1 and LC3 II protein expression levels in primary neurons, while MSC-separated coculture significantly decreased Beclin 1 and LC3 II protein expression levels and induced p62 protein expression levels after OGD injury for 12 h and 24 h. These data were consistent with the changes in vivo. In addition, transmission electron microscopy was used to observe the numbers of autophagosomes in the OGD-damaged neurons following coculture with MSCs. The number of autophagosomes was significantly increased at 12 h and 24 h in the neurons with OGD injury. Interestingly, the increase in autophagosomes was decreased after separate MSC coculture (Figure 3(e)). The above results suggest that MSC-separated coculture could downregulate autophagy in neurons with OGD injury at the acute stage through paracrine secretion.
3.4. Silencing IL-6 Attenuated MSC Inhibition of Autophagy in OGD-Injured Neurons
Our previous study revealed that the neuroprotective function of MSCs was closely associated with IL-6 secretion and that siIL-6 lentivirus could effectively inhibit IL-6 release in MSCs . To confirm the effect of endogenous IL-6 in MSCs on neuronal autophagy after injury, siIL-6 MSCs or GFP MSCs were cocultured with primary hippocampal neurons injured by OGD. As shown in Figures 4(a) and 4(b), the IL-6 levels at 12 h and 24 h after OGD were significantly lower in neurons with siIL-6 MSC-separated coculture than in those with GFP MSC coculture. Moreover, the expression levels of Beclin 1 and LC3 II were significantly higher in the OGD-damaged neurons following coculture with siIL-6 MSCs, and the p62 protein expression levels were significantly decreased (Figures 4(c)–4(e)). However, the number of autophagosomes at 12 h and 24 h was significantly increased in the siIL-6 MSC group compared with the GFP MSC group (Figure 4(f)). These results demonstrate that IL-6 secreted from MSCs could regulate autophagy in OGD-damaged neurons.
3.5. siIL-6 MSC Transplantation Weakened the Suppressive Effects of MSCs on Autophagy in the Hippocampus of HIBD Rats
When IL-6 expression levels were significantly decreased in the rat hippocampus following siIL-6 MSC transplantation (Figures 5(a) and 5(b)), the changes in Beclin 1, LC3 II, and p62 protein expressions completely mirrored the in vitro results (Figures 5(c)–5(e)). The results in vivo and in vitro indicate that endogenous IL-6 from MSCs can regulate autophagy in HIBD hippocampus neurons during the acute phase.
3.6. Effect of siIL-6 MSC Transplantation on AMPK/mTOR Signaling in the Rat Hippocampus after HIBD
Furthermore, to explore the possible mechanism of IL-6-mediated autophagy, we investigated the AMPK/mTOR signaling pathway, which is downstream of IL-6 and involved in autophagy. Hippocampal p-AMPK protein expression levels were significantly increased, and p-mTOR protein expression levels were significantly reduced in the HIBD+siIL-6 MSC group compared with the HIBD+GFP MSC group (Figures 6(a)–6(c)). Similarly, p-AMPK expression levels were significantly higher, and p-mTOR levels were significantly lower in the OGD+siIL-6 MSC group than in the OGD+GFP MSC group (Figures 6(d)–6(f)). The above results suggest that IL-6 secretion from MSCs may inhibit the AMPK/mTOR signaling pathway to regulate autophagy in HIBD hippocampal neurons.
The present study investigated whether MSCs regulate autophagy in hippocampal neurons to alleviate the learning-memory impairment of HIBD rats through endogenous IL-6 secretion. The current study demonstrated that IL-6 from MSCs reduced neuron autophagy by suppressing the AMPK/mTOR signaling pathway. This effect consequently improved the learning-memory function in HIBD rats.
Increasing evidence indicates that MSCs have potent therapeutic benefits for functional recovery after brain damage [11, 19], which improved overall neurobehavioral in both sensorimotor and cognitive testing . In the present study, we also revealed that MSC transplantation ameliorated the learning-memory deficit in HIBD rats. The potential mechanisms of the MSC-induced neuroprotective effects following brain injury include cell replacement, trophic support from MSCs, immunomodulation, and endogenous brain restoration stimulation. An increasing number of studies have indicated the immunomodulatory function of MSCs in the damaged microenvironment after HIBD [19, 21, 22]. Some studies have shown that MSCs display neurorestorative effects through enhancing autolysosome formation to induce Aβ clearance in Aβ-treated AD models  or modulating a-synuclein expression in neurotoxin-treated Parkinson’s disease (PD) models . These findings suggest that MSCs play a protective role by regulating autophagy following injury, but autophagy regulation by MSCs in the hippocampal neurons of neonatal rats with HIBD has rarely been reported. According to our results, both MSC transplantation and separate coculture ameliorated the increased Beclin 1 and LC3 II expression levels and the decreased p62 protein levels induced by HIBD or OGD damage. Additionally, the number of autophagosomes in the neurons with OGD injury was reduced at the acute stage by MSCs coculture. Our results strongly indicate that MSCs suppress hippocampal neuron autophagy in HIBD rats, in contrast to the reports by Shin et al. and Park et al. [12, 23]. This difference is due to the different disease models, experimental animal ages, insult severity, ischemia stages, and autophagy degrees. Both PD and AD are chronic diseases of the nervous system, but the model used in our study is neonatal HIBD, which is an acute brain injury disease in the neonatal period.
In our previous study, we found that both transplanting MSCs and coculture in vitro could facilitate IL-6 release into the injured microenvironment. It was also shown that IL-6 in the damaged hippocampal microenvironment was primarily due to MSC transplantation, even though the IL-6 concentration was slightly increased after HIBD . In the central nervous system (CNS), the IL-6 secretion level is low under normal conditions but is significantly induced under disease conditions . However, the role of IL-6 in the damaged brain is controversial. IL-6 upregulation might increase harmful factors and mediate inflammatory cascades to effect the vascular endothelium and exacerbate cerebral ischemic damage . However, IL-6 facilitates posttraumatic healing of the CNS via enhancing angiogenesis . Both in vivo and in vitro results revealed that blocking IL-6 in MSCs significantly increases the levels of the autophagy-associated proteins Beclin 1 and LC3 II in both HIBD rat hippocampi and OGD-injured neurons; IL-6 silencing also reduced p62 protein expression levels. Moreover, the number of autophagosomes was significantly increased in the OGD-injured neurons following separate coculture with siIL-6 MSCs. These results are consistent with the findings of Chang et al. and Delk and Farach-Carson [27, 28], which demonstrate that endogenous IL-6 from MSCs can regulate hippocampal neuron autophagy following HIBD.
Mammalian AMPK has been confirmed to be a downstream target of IL-6. IL-6 can suppress mTOR, which is a pivotal factor in the autophagic signaling pathway, in an AMPK-dependent and STAT3-independent manner . Under physiological and disease conditions, AMPK is activated by increased AMP and/or decreased ATP in the cytoplasm . In this study, we found that IL-6 suppression significantly increased p-AMPK protein expression levels after siIL-6 MSC transplantation or coculture, suggesting that IL-6 in the damaged microenvironment can negatively regulate AMPK phosphorylation levels. Therefore, we speculated that IL-6 may inhibit the nonclassical AMPK pathway via the gp130-IL-6R receptor complex . However, the details of this molecular mechanism require further study. mTOR is negatively regulated by AMPK signaling and plays multiple biological functions in the CNS, particularly in autophagy . A decrease in the ATP concentration during ischemia activates AMPK, which subsequently suppresses mTOR activity to induce autophagy . Our in vivo and in vitro observations indicate that phospho-mTOR protein expression levels were significantly decreased by siIL-6 MSCs. These results indicate that silencing IL-6 can suppress mTOR phosphorylation levels through p-AMPK activation. Active AMPK leads to the phosphorylation and activation of TSC1/2 and the inhibition of mTORC1 activity through Rheb . The above findings demonstrate that MSCs suppress autophagy in hippocampal neurons to ameliorate the functional outcomes of HIBD, and this neuroprotective effect may partly involve the biofunction of endogenous IL-6 to reduce the AMPK/mTOR signaling pathway.
In the current study, we demonstrate the biological effect of endogenous IL-6 of mesenchymal stem cell on hippocampal autophagy after HIBD injury. Combined with our previous finding of IL-6 in MSCs facilitating antiapoptosis of injured astrocytes , we can conclude that MSC transplantation regulates injured microenvironment to ameliorate learning-memory dysfunction through both repressing neuron autophagy and enhancing antiapoptosis of astrocytes. Of course, our study had some limitations. The experimental data was mainly displayed in western blotting, no combined with the results of IHC or IF to confirm the regional change after injury with or without MSCs treatment, because the hypothesis of the present study was whether endogenous IL-6 of mesenchymal stem cell could suppress on hippocampal neuron autophagy after HIBD injury, rather than the localization of autophagy. Therefore, at first, we measured the levels of autophagy-associated protein expressions in the hippocampus of rats following HIBD with or without MSCs transplantation, as well as in the hippocampal neurons after OGD with or without MSCs coculture. Secondly, the autophagosomes were observed in the hippocampal primary neurons injured by OGD with or without MSCs or siIL-6-MSC coculture by transmission electron microscopy. In fact, autophagy occurs in all parts of the brain during the acute stage of HIBD injury, while our study only focused on hippocampal neuronal autophagy.
This study revealed for the first time that endogenous IL-6 in MSCs may suppress autophagy in hippocampal neurons through inhibiting the AMPK/mTOR signaling pathway (Figure 7).
|HIBD:||Hypoxic-ischemic brain damage|
|OGD:||Oxygen and glucose deprivation|
|MSCs:||Mesenchymal stromal cells|
|Beclin-1:||Homologue of yeast Atg6|
|LC3:||Microtubule-associated protein 1 light chain 3|
|P62:||Sequestosome 1, SQSTM1|
|p-mTOR:||Phospho-mammalian target of rapamycin|
|p-AMPK:||Phospho-mammalian AMP-activated protein kinase|
|SD rats:||Sprague Dawley rats|
|SEM:||Standard error of the mean|
|ANOVA:||One-way analysis of variance.|
The data used to support the findings of this study were supplied by Miao Yang and cannot be made freely available. Requests for access to these data should be made to [Miao Yang, firstname.lastname@example.org].
All authors have read the journal’s position on issues regarding ethical publication, and all authors have approved the final version of the manuscript. Ethical approval was received for the use of animals. All procedures performed in studies involving animals were in accordance with the ethical standards of the institution (Animal Care and Use Committee of Chongqing Medical University SCXK (Yu) 2012-0015).
Conflicts of Interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
All authors contributed substantially to the conception and design of the study and to the critical review of the manuscript. MY performed the experiments and analyzed the data. WS analyzed the data. LX, MH, and YG provided technical guidance. MY, WS, and JC wrote the manuscript. JC designed the study. JC and XL provided financial support for the study. All authors read and approved the final manuscript. Miao Yang and Wuqing Sun are the co-first authors.
We thank Professors Jie Chen and Xiaohua Liang for providing financial support, and we thank all authors for their contributions to this study. This work was supported in part by a grant to Jie Chen from the National Natural Science Foundation of China (81271385) for the treatment of rats and primary hippocampal neurons and the performance of all experiments. Publication costs are funded by a grant to Jie Chen from the Stem Cell Therapy for Special Study of the Children’s Hospital of Chongqing Medical University (SCT-201203). The funder designed the experiment and provided financial support for this research.
- T. Yasuhara, N. Matsukawa, G. Yu et al., “Behavioral and histological characterization of intrahippocampal grafts of human bone marrow-derived multipotent progenitor cells in neonatal rats with hypoxic-ischemic injury,” Cell Transplantation, vol. 15, no. 3, pp. 231–238, 2017.
- K. A. Allen and D. H. Brandon, “Hypoxic ischemic encephalopathy: pathophysiology and experimental treatments,” Newborn and Infant Nursing Reviews, vol. 11, no. 3, pp. 125–133, 2011.
- M. A. Moskowitz, E. H. Lo, and C. Iadecola, “The science of stroke: mechanisms in search of treatments,” Neuron, vol. 67, no. 2, pp. 181–198, 2010.
- F. Adhami, A. Schloemer, and C. Y. Kuan, “The roles of autophagy in cerebral ischemia,” Autophagy, vol. 3, no. 1, pp. 42–44, 2014.
- M. Koike, M. Shibata, M. Tadakoshi et al., “Inhibition of autophagy prevents hippocampal pyramidal neuron death after hypoxic-ischemic injury,” The American Journal of Pathology, vol. 172, no. 2, pp. 454–469, 2008.
- F. Tian, K. Deguchi, T. Yamashita et al., “In vivo imaging of autophagy in a mouse stroke model,” Autophagy, vol. 6, no. 8, pp. 1107–1114, 2014.
- E. Wong and A. M. Cuervo, “Autophagy gone awry in neurodegenerative diseases,” Nature Neuroscience, vol. 13, no. 7, pp. 805–811, 2010.
- R. A. Nixon, “Autophagy in neurodegenerative disease: friend, foe or turncoat,” Trends in Neurosciences, vol. 29, no. 9, pp. 528–535, 2006.
- R. Banerjee, M. F. Beal, and B. Thomas, “Autophagy in neurodegenerative disorders: pathogenic roles and therapeutic implications,” Trends in Neurosciences, vol. 33, no. 12, pp. 541–549, 2010.
- A. W. Phillips, M. V. Johnston, and A. Fatemi, “The potential for cell-based therapy in perinatal brain injuries,” Translational Stroke Research, vol. 4, no. 2, pp. 137–148, 2013.
- Y. Gu, M. He, X. Zhou et al., “Endogenous IL-6 of mesenchymal stem cell improves behavioral outcome of hypoxic-ischemic brain damage neonatal rats by supressing apoptosis in astrocyte,” Scientific Reports, vol. 6, no. 1, article 18587, 2016.
- J. Y. Shin, H. J. Park, H. N. Kim et al., “Mesenchymal stem cells enhance autophagy and increase β-amyloid clearance in Alzheimer disease models,” Autophagy, vol. 10, no. 1, pp. 32–44, 2013.
- J. E. Rice, R. C. Vannucci, and J. B. Brierley, “The influence of immaturity on hypoxic-ischemic brain damage in the rat,” Annals of Neurology, vol. 9, no. 2, pp. 131–141, 1981.
- Y. Bi, M. Gong, Y. He et al., “AP2α transcriptional activity is essential for retinoid-induced neuronal differentiation of mesenchymal stem cells,” The International Journal of Biochemistry & Cell Biology, vol. 46, pp. 148–160, 2014.
- R. Morris, “Developments of a water-maze procedure for studying spatial learning in the rat,” Journal of Neuroscience Methods, vol. 11, no. 1, pp. 47–60, 1984.
- M. L. He, J. J. Liu, Y. Gu, T. Y. Li, J. Chen et al., “Effects of inhibiting secretion of mesenchymal stromal cellss originated interleukin-6 on oxygen glucose deprivation injured PC12 cells,” Journal of Shanghai Jiao Tong University Medical Science, vol. 34, pp. 1435–1447, 2014.
- J. L. M. Madrigal, C. D. Russo, V. Gavrilyuk, and D. L. Feinstein, “Effects of noradrenaline on neuronal NOS2 expression and viability,” Antioxidants & Redox Signaling, vol. 8, no. 5-6, pp. 885–892, 2006.
- M. Yang, M. L. He, Y. Gu, T. Yang, T. Y. Li, J. Chen et al., “The modulation of mesenchymal stromal cells transplantation on autophagy in hippocampus of hypoxic-ischemic brain damage rats,” Journal of Shanghai Jiao Tong University Medical Science, vol. 37, pp. 1608–1615, 2014.
- C. T. J. van Velthoven, A. Kavelaars, F. van Bel, and C. J. Heijnen, “Mesenchymal stem cell treatment after neonatal hypoxic-ischemic brain injury improves behavioral outcome and induces neuronal and oligodendrocyte regeneration,” Brain, Behavior, and Immunity, vol. 24, no. 3, pp. 387–393, 2010.
- J. Archambault, A. Moreira, D. McDaniel, L. Winter, L. Z. Sun, and P. Hornsby, “Therapeutic potential of mesenchymal stromal cells for hypoxic ischemic encephalopathy: a systematic review and meta-analysis of preclinical studies,” PLoS One, vol. 12, no. 12, article e0189895, 2017.
- C. T. J. van Velthoven, R. A. Sheldon, A. Kavelaars et al., “Mesenchymal stem cell transplantation attenuates brain injury after neonatal stroke,” Stroke, vol. 44, no. 5, pp. 1426–1432, 2013.
- C. T. van Velthoven, A. Kavelaars, F. van Bel, and C. J. Heijnen, “Repeated mesenchymal stem cell treatment after neonatal hypoxia-ischemia has distinct effects on formation and maturation of new neurons and oligodendrocytes leading to restoration of damage, corticospinal motor tract activity, and sensorimotor function,” The Journal of Neuroscience, vol. 30, no. 28, pp. 9603–9611, 2010.
- H. J. Park, J. Y. Shin, H. N. Kim, S. H. Oh, and P. H. Lee, “Neuroprotective effects of mesenchymal stem cells through autophagy modulation in a parkinsonian model,” Neurobiology of Aging, vol. 35, no. 8, pp. 1920–1928, 2014.
- A. Spooren, K. Kolmus, G. Laureys et al., “Interleukin-6, a mental cytokine,” Brain Research Reviews, vol. 67, no. 1-2, pp. 157–183, 2011.
- J. Huang, U. M. Upadhyay, and R. J. Tamargo, “Inflammation in stroke and focal cerebral ischemia,” Surgical Neurology, vol. 66, no. 3, pp. 232–245, 2006.
- K. R. Swartz, F. Liu, D. Sewell et al., “Interleukin-6 promotes post-traumatic healing in the central nervous system,” Brain Research, vol. 896, no. 1-2, pp. 86–95, 2001.
- P. C. Chang, T. Y. Wang, Y. T. Chang et al., “Autophagy pathway is required for IL-6 induced neuroendocrine differentiation and chemoresistance of prostate cancer LNCaP cells,” PLoS One, vol. 9, no. 2, article e88556, 2014.
- N. A. Delk and M. C. Farach-Carson, “Interleukin-6: a bone marrow stromal cell paracrine signal that induces neuroendocrine differentiation and modulates autophagy in bone metastatic PCa cells,” Autophagy, vol. 8, no. 4, pp. 650–663, 2014.
- J. P. White, M. J. Puppa, S. Gao, S. Sato, S. L. Welle, and J. A. Carson, “Muscle mTORC1 suppression by IL-6 during cancer cachexia: a role for AMPK,” American Journal of Physiology. Endocrinology and Metabolism, vol. 304, no. 10, pp. E1042–E1052, 2013.
- Z. Yang and D. J. Klionsky, “Mammalian autophagy: core molecular machinery and signaling regulation,” Current Opinion in Cell Biology, vol. 22, no. 2, pp. 124–131, 2010.
- C. H. Jung, S. H. Ro, J. Cao, N. M. Otto, and D. H. Kim, “mTOR regulation of autophagy,” FEBS Letters, vol. 584, no. 7, pp. 1287–1295, 2010.
- F. Xu, J. H. Gu, and Z. H. Qin, “Neuronal autophagy in cerebral ischemia,” Neuroscience Bulletin, vol. 28, no. 5, pp. 658–666, 2012.
- P. Wang, Y. F. Guan, H. du, Q. W. Zhai, D. F. Su, and C. Y. Miao, “Induction of autophagy contributes to the neuroprotection of nicotinamide phosphoribosyltransferase in cerebral ischemia,” Autophagy, vol. 8, no. 1, pp. 77–87, 2014.
Copyright © 2020 Miao Yang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.